The Society for Immunotherapy of Cancer (SITC) honors notable
contributors to the cancer immunotherapy field each year. SITC is
thrilled to announce its 2024 Annual Awards recipients who will be
honored at its 39th Annual Meeting & Pre-Conference Programs,
taking place November 6–10, 2024 in Houston, TX.
MILWAUKEE, July 22,
2024 /PRNewswire-PRWeb/ -- The Society for
Immunotherapy of Cancer (SITC) honors notable contributors to the
cancer immunotherapy field each year. SITC is thrilled to announce
its 2024 Annual Awards recipients who will be honored at its 39th
Annual Meeting & Pre-Conference Programs, taking place November
6–10, 2024 in Houston, TX.
"The Annual Awards celebrate individuals
whose significant contributions directly benefit patients and
advance the field of immuno-oncology." - Leisha A. Emens, MD, PhD, SITC President
"The Annual Awards celebrate individuals whose significant
contributions directly benefit patients and advance the field of
immuno-oncology," said SITC President Leisha A. Emens, MD, PhD. "SITC is honored to
acknowledge these exceptional members of our community and we look
forward to spotlighting them at SITC 2024."
The recipients are:
2025 Richard V. Smalley Memorial Award and Lectureship
Ira Mellman, PhD – Genentech
2024 Richard V. Smalley Memorial Award and Lectureship
Elizabeth M. Jaffee, MD, FAIO,
FAACR, FACP, FAAAS – Sidney Kimmel Cancer Center at Johns Hopkins
2024 SITC Lifetime Achievement Award
Bernard A. Fox, PhD – Earle A.
Chiles Research Institute, Providence Cancer Institute
2024 Tara Withington Public Service Award
Deborah Collyar, B.Sci – Patient
Advocates in Research (PAIR)
2024 Pedro J. Romero Service to JITC Award
Andrea Kunz – Society for
Immunotherapy of Cancer
To learn more about the Annual Awards and to view past
recipients, visit SITC's website. SITC will announce a call for
nominations for the 2025 Annual Awards in the spring.
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC)
is a nonprofit organization of medical professionals dedicated to
improving cancer patient outcomes by advancing the development,
science and application of cancer immunotherapy and tumor
immunology. SITC is comprised of influential basic and
translational scientists, practitioners, health care professionals,
government leaders and industry professionals around the globe.
Through educational initiatives that foster scientific exchange and
collaboration among leaders in the field, SITC aims to one day make
the word "cure" a reality for cancer patients everywhere. Learn
more about SITC, our educational offerings and other resources at
sitcancer.org and follow us on X, LinkedIn, Facebook, Instagram and
YouTube.
Media Contact
Thomas Martin, SITC,
414.271.2456, tmartin@sitcancer.org, sitcancer.org
Twitter
View original content to download
multimedia:https://www.prweb.com/releases/society-for-immunotherapy-of-cancer-announces-annual-award-recipients-302202310.html
SOURCE SITC